Publications
Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a...
Lunit said Tuesday that it has published research showing that its AI biomarker platform, Lunit SCOPE, can improve HER2 (human epidermal growth factor receptor 2) diagnosis in advanced bile duct cancer. The study was published in Laboratory...
October 21, 2025 Salt Lake City—ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in...
Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the...
Mount Sinai: Real-time trial shows AI could speed cancer care New York, NY (July 09, 2025) A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that...
From the Cureus Journal of Medicine, researchers publish a pilot study of breast cancer Histopathological Image Classification Using Google Teachable Machine. Read the Abstract below. Abstract Introduction Breast cancer remains a major...
